Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $688.24M.
ENTERPRISE VALUE (EV)
$688.24M
Cytek Biosciences, Inc.
Market Cap
$772.27M
Enterprise Value (EV)
$688.24M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | $772.27M | $688.24M |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $772.90M | $791.26M |
| Geron Corporation (GERN)vs › | $773.03M | $832.53M |
| Attovia Therapeutics, Inc. (ATTO)vs › | $777.55M | $749.05M |
| Design Therapeutics, Inc. (DSGN)vs › | $759.16M | $748.29M |
| Mesa Laboratories, Inc. (MLAB)vs › | $788.35M | $859.01M |
| AdaptHealth Corp. (AHCO)vs › | $791.18M | $2.81B |
| Candel Therapeutics, Inc. (CADL)vs › | $752.12M | $600.07M |
| Gyre Therapeutics, Inc. (GYRE)vs › | $808.29M | $768.43M |
| Avalo Therapeutics, Inc. (AVTX)vs › | $734.60M | $649.46M |
Market Cap
$772.27M
Total Debt
$6.82M
Cash
$90.85M
Enterprise Value
$688.24M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
